Sylvia Kurz
Neurology · New Haven, CTNPI 1619278173
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.8%), food and beverage and education — rather than concentrated in one kind of arrangement. 4 manufacturers reported payments, led by Biogen at 59.8% of the total. Reporting peaked in 2020 at $400 and has fallen 83.3% since, to $67 in 2025. That places this record below the midpoint for neurology clinicians in CT, where the typical reported total is $893.
Across 4 payments — averaging $167.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$400
- Agios Pharmaceuticals, Inc.$185
- Novartis$67
- Merck$18
Across 18 payments — averaging $14,044 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$100K
- EMD Serono, Inc.$69K
- Boehringer Ingelheim$30K
- Monteris Medical Corporation$27K
- Insightec,ltd$27K
What the payments were for
- Consulting fees$40060%
- Food & beverage$25138%
- Education$183%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 1 | $400 |
| Agios Pharmaceuticals, Inc. | 1 | $185 |
| Novartis | 1 | $67 |
| Merck | 1 | $18 |
How this compares
$669 in reported general payments places this provider in the 45th percentile of 280 neurology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in New Haven
- Sharon StollNew Haven$822K
- Mary BaileyNew Haven$630K
- Stephen WaxmanNew Haven$252K
- Ariel LeflandNew Haven$220K
- David RussellNew Haven$208K
- Richard NowakNew Haven$126K
- David HaflerNew Haven$118K
- Kenneth MarekNew Haven$86K
- Daniel DicapuaNew Haven$85K
- Lee SchwammNew Haven$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.